2023
The case fatality rate of COVID‐19 during the Delta and the Omicron epidemic phase: A meta‐analysis
Kim K, Cho K, Song J, Rahmati M, Koyanagi A, Lee S, Yon D, Shin J, Smith L. The case fatality rate of COVID‐19 during the Delta and the Omicron epidemic phase: A meta‐analysis. Journal Of Medical Virology 2023, 95: e28522. PMID: 36691933, DOI: 10.1002/jmv.28522.Peer-Reviewed Original Research
2022
Meta-analysis of nationwide SARS-CoV-2 infection fatality rates in India
Zimmermann L, Mukherjee B. Meta-analysis of nationwide SARS-CoV-2 infection fatality rates in India. PLOS Global Public Health 2022, 2: e0000897. PMID: 36962545, PMCID: PMC10021252, DOI: 10.1371/journal.pgph.0000897.Peer-Reviewed Original ResearchMortality dataExcess deathsTotal deathUnderreporting of deathsMeta-analysisGlobal Index MedicusSARS-CoV-2 infection fatality rateFatality rateInfection fatality rateUnderserved populationsSearch of databases PubMedMeta-analysis frameworkAscertainment rateSystematic reviewPooled estimatesDatabases PubMedPRISMA guidelinesConfidence intervalsAt-riskMeta-analyzedIndex MedicusDeath studiesCOVID mortalityUnderreportingDemographic groupsThe risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies
Manry J, Bastard P, Gervais A, Le Voyer T, Rosain J, Philippot Q, Michailidis E, Hoffmann HH, Eto S, Garcia-Prat M, Bizien L, Parra-Martínez A, Yang R, Haljasmägi L, Migaud M, Särekannu K, Maslovskaja J, de Prost N, Tandjaoui-Lambiotte Y, Luyt CE, Amador-Borrero B, Gaudet A, Poissy J, Morel P, Richard P, Cognasse F, Troya J, Trouillet-Assant S, Belot A, Saker K, Garçon P, Rivière JG, Lagier JC, Gentile S, Rosen LB, Shaw E, Morio T, Tanaka J, Dalmau D, Tharaux PL, Sene D, Stepanian A, Mégarbane B, Triantafyllia V, Fekkar A, Heath JR, Franco JL, Anaya JM, Solé-Violán J, Imberti L, Biondi A, Bonfanti P, Castagnoli R, Delmonte OM, Zhang Y, Snow AL, Holland SM, Biggs CM, Moncada-Vélez M, Arias AA, Lorenzo L, Boucherit S, Anglicheau D, Planas AM, Haerynck F, Duvlis S, Ozcelik T, Keles S, Bousfiha AA, Bakkouri J, Ramirez-Santana C, Paul S, Pan-Hammarström Q, Hammarström L, Dupont A, Kurolap A, Metz CN, Aiuti A, Casari G, Lampasona V, Ciceri F, Barreiros LA, Dominguez-Garrido E, Vidigal M, Zatz M, van de Beek D, Sahanic S, Tancevski I, Stepanovskyy Y, Boyarchuk O, Nukui Y, Tsumura M, Vidaur L, Tangye SG, Burrel S, Duffy D, Quintana-Murci L, Klocperk A, Kann NY, Shcherbina A, Lau YL, Leung D, Coulongeat M, Marlet J, Koning R, Reyes LF, Chauvineau-Grenier A, Venet F, Monneret G, Nussenzweig MC, Arrestier R, Boudhabhay I, Baris-Feldman H, Hagin D, Wauters J, Meyts I, Dyer AH, Kennelly SP, Bourke NM, Halwani R, Sharif-Askari FS, Dorgham K, Sallette J, Sedkaoui SM, AlKhater S, Rigo-Bonnin R, Morandeira F, Roussel L, Vinh DC, Erikstrup C, Condino-Neto A, Prando C, Bondarenko A, Spaan AN, Gilardin L, Fellay J, Lyonnet S, Bilguvar K, Lifton RP, Mane S, Lab H, Clinicians C, Clinicians C, Group N, Group N, Danish C, Study D, St. James's Hospital S, Group F, COVID-Group I, Consortium T, Cohort C, Investigators A, Effort C, Group C, cohort C, Study 3, Health-Care C, du Sang Study group E, Anderson M, Boisson B, Béziat V, Zhang S, Andreakos E, Hermine O, Pujol A, Peterson P, Mogensen T, Rowen L, Mond J, Debette S, de Lamballerie X, Burdet C, Bouadma L, Zins M, Soler-Palacin P, Colobran R, Gorochov G, Solanich X, Susen S, Martinez-Picado J, Raoult D, Vasse M, Gregersen P, Piemonti L, Rodríguez-Gallego C, Notarangelo L, Su H, Kisand K, Okada S, Puel A, Jouanguy E, Rice C, Tiberghien P, Zhang Q, Casanova J, Abel L, Cobat A, Zhang P, Seeleuthner Y, Talouarn E, Marchal A, Matuozzo D, de la Chapelle A, Chen J, Chrabieh M, Liu D, Nemirowskaya Y, Cruz I, Materna M, Pelet S, Thibault C, Liu Z, Abad J, Accordino G, Achille C, Aguilera-Albesa S, Aguiló-Cucurull A, Aiuti A, Özkan E, Darazam I, Albisures J, Aldave J, Ramos M, Khan T, Aliberti A, Nadji S, Alkan G, AlKhater S, Allardet-Servent J, Allende L, Alonso-Arias R, Alshahrani M, Alsina L, Alyanakian M, Borrero B, Amoura Z, Antolí A, Arrestier R, Aubart M, Auguet T, Avramenko I, Aytekin G, Azot A, Bahram S, Bajolle F, Baldanti F, Baldolli A, Ballester M, Feldman H, Barrou B, Barzaghi F, Basso S, Bayhan G, Belot A, Bezrodnik L, Bilbao A, Blanchard-Rohner G, Blanco I, Blandinières A, Blázquez-Gamero D, Bleibtreu A, Bloomfield M, Bolivar-Prados M, Bondarenko A, Borghesi A, Borie R, Botdhlo-Nevers E, Bousfiha A, Bousquet A, Boutolleau D, Bouvattier C, Boyarchuk O, Bravais J, Briones M, Brunner M, Bruno R, Bueno M, Bukhari H, Bustamante J, Agra J, Capra R, Carapito R, Carrabba M, Casari G, Casasnovas C, Caseris M, Cassaniti I, Castelle M, Castelli F, de Vera M, Castro M, Catherinot E, Celik J, Ceschi A, Chalumeau M, Charbit B, Cheng M, Clavé P, Clotet B, Codina A, Cohen Y, Colobran R, Comarmond C, Combes A, Comoli P, Corsico A, Coşkuner T, Cvetkovski A, Cyrus C, Dalmau D, Danion F, Darley D, Das V, Dauby N, Dauger S, De Munter P, de Pontual L, Dehban A, Delplancq G, Demoule A, Desguerre I, Di Sabatino A, Diehl J, Dobbelaere S, Domínguez-Garrido E, Dubost C, Ekwall O, Bozdemir Ş, Elnagdy M, Emiroglu M, Endo A, Erdeniz E, Aytekin S, Lasa M, Euvrard R, Fabio G, Faivre L, Falck A, Fartoukh M, Faure M, Arquero M, Ferrer R, Ferreres J, Flores C, Francois B, Fumadó V, Fung K, Fusco F, Gagro A, Solis B, Gaussem P, Gayretli Z, Gil-Herrera J, Gilardin L, Gatineau A, Girona-Alarcón M, Godínez K, Goffard J, Gonzales N, Gonzalez-Granado L, González-Montelongo R, Guerder A, Gülhan B, Gumucio V, Hanitsch L, Gunst J, Gut M, Hadjadj J, Haerynck F, Halwani R, Hammarström L, HANCERLI S, Hariyan T, Hatipoglu N, Heppekcan D, Hernandez-Brito E, Ho P, Holanda-Peña M, Horcajada J, Hraiech S, Humbert L, Hung I, Iglesias A, Íñigo-Campos A, Jamme M, Arranz M, Jimeno M, Jordan I, Kanık-Yüksek S, Kara Y, Karahan A, Karbuz A, Yasar K, Kasapcopur O, Kashimada K, Keles S, Demirkol Y, Kido Y, Kizil C, Kılıç A, Klocperk A, Daganou M, Koukaki E, Koutsoukou A, Rapti V, Syrigos K, Król Z, Ksouri H, Kuentz P, Kwan A, Kwan Y, Kwok J, Lagier J, Lam D, Conti F, Pession A, Lampropoulou V, Lanternier F, Lau Y, Le Bourgeois F, Leo Y, Lopez R, Leung D, Levin M, Levy M, Lévy R, Li Z, Lilleri D, Lima E, Linglart A, López-Collazo E, Lorenzo-Salazar J, Louapre C, Lubetzki C, Lung K, Luyt C, Lye D, Magnone C, Mansouri D, Marchioni E, Marioli C, Marjani M, Marques L, Pereira J, Martín-Nalda A, Pueyo D, Martinez-Picado J, Marzana I, Mata-Martínez C, Mathian A, Matos L, Matthews G, Mayaux J, McLaughlin-Garcia R, Meersseman P, Mège J, Mekontso-Dessap A, Melki I, Meloni F, Meritet J, Merlani P, Akcan Ö, Meyts I, Mezidi M, Migeotte I, Millereux M, Million M, Mirault T, Mircher C, Mirsaeidi M, Mizoguchi Y, Modi B, Mojoli F, Moncomble E, Melián A, Martinez A, Morandeira F, Morange P, Mordacq C, Morelle G, Mouly S, Muñoz-Barrera A, Nafati C, Nagashima S, Nakagama Y, Neven B, Neves J, Ng L, Ng Y, Nielly H, Medina Y, Cuadros E, Ocejo-Vinyals J, Okamoto K, Oualha M, Ouedrani A, Özçelik T, Ozkaya-Parlakay A, Pagani M, Pan-Hammarström Q, Papadaki M, Parizot C, Parola P, Pascreau T, Paul S, Paz-Artal E, Pedraza-Sánchez S, Gálvez-Romero J, Pellecer N, Pellegrini S, de Diego R, Pérez-Fernández X, Philippe A, Philippot Q, Picod A, de Chambrun M, Piralla A, Planas-Serra L, Ploin D, Poissy J, Poncelet G, Poulakou G, Pouletty M, Pourshahnazari P, Qiu-Chen J, Quentric P, Rambaud T, Raoult D, Raoult V, Rebillat A, Redin C, Resmini L, Ricart P, Richard J, Rigo-Bonnin R, rivet N, Rivière J, Rocamora-Blanch G, Rodero M, Rodrigo C, Rodriguez L, Rodriguez-Gallego C, Rodriguez-Palmero A, Romero C, Rothenbuhler A, Roux D, Rovina N, Rozenberg F, Ruch Y, Ruiz M, del Prado M, Ruiz-Rodriguez J, Sabater-Riera J, Saks K, Salagianni M, Sanchez O, Sánchez-Montalvá A, Sánchez-Ramón S, Schidlowski L, Schluter A, Schmidt J, Schmidt M, Schuetz C, Schweitzer C, Scolari F, Sediva A, Seijo L, Seminario A, Sene D, Seng P, Senoglu S, Seppänen M, Llovich A, Shahrooei M, Shcherbina A, Siguret V, Siouti E, Smadja D, Smith N, Sobh A, Solanich X, Solé-Violán J, Soler C, Soler-Palacín P, Sözeri B, Stella G, Stepanovskiy Y, Stoclin A, Taccone F, Tandjaoui-Lambiotte Y, Taupin J, Tavernier S, Vidaur L, Terrier B, Thiery G, Thorball C, Thorn K, Thumerelle C, Tipu I, Tolstrup M, Tomasoni G, Toubiana J, Alvarez J, Trouillet-Assant S, Troya J, Tsang O, Tserel L, Tso E, Tucci A, Öz Ş, Ursini M, Utsumi T, Uzunhan Y, Vabres P, Valencia-Ramos J, Van Den Rym A, Vandernoot I, Velez-Santamaria V, Veliz S, Vidigal M, Viel S, Villain C, Vilaire-Meunier M, Villar-García J, Vincent A, Vogt G, Voiriot G, Volokha A, Vuotto F, Wauters E, Wauters J, Wu A, Wu T, Yahşi A, Yesilbas O, Yildiz M, Young B, Yükselmiş U, Zatz M, Ghirardello S, Zuccaro V, de Andrés A, Van Praet J, Lambrecht B, Van Braeckel E, Bosteels C, Hoste L, Hoste E, Bauters F, De Clercq J, Heijmans C, Slabbynck H, Naesens L, Florkin B, Boulanger C, Vanderlinden D, Foti G, Bellani G, Citerio G, Contro E, Pesci A, Valsecchi M, Cazzaniga M, Danielson J, Dobbs K, Kashyap A, Ding L, Dalgard C, Sottini A, Quaresima V, Quiros-Roldan E, Rossi C, Bettini L, D’Angio M, Beretta I, Montagna D, Licari A, Marseglia G, Batten I, Reddy C, McElheron M, Noonan C, Connolly E, Fallon A, Storgaard M, Jørgensen S, Tolstrup M, Erikstrup C, Pedersen O, Sørensen E, Mikkelsen S, Dinh K, Larsen M, Paulsen I, Von Stemann J, Hansen M, Ostrowski S, Townsend L, Cheallaigh C, Bergin C, Martin-Loeches I, Dunne J, Conlon N, Bourke N, O’Farrelly C, Abel L, Allavena C, Andrejak C, Angoulvant F, Azoulay C, Bachelet D, Bartoli M, Basmaci R, Behillill S, Beluze M, Benech N, Benkerrou D, Bhavsar K, Bitker L, Bouadma L, Bouscambert-Duchamp M, Paz P, Cervantes-Gonzalez M, Chair A, Chirouze C, Coelho A, Cordel H, Couffignal C, Couffin-Cadiergues S, d’Ortenzio E, De Montmollin E, Debard A, Debray M, Deplanque D, Descamps D, Desvallée M, Diallo A, Diehl J, Diouf A, Dorival C, Dubos F, Duval X, Eloy P, Enouf V, Epaulard O, Esperou H, Esposito-Farase M, Etienne M, Garot D, Gault N, Gaymard A, Ghosn J, Gigante T, Gilg M, Goehringer F, Guedj J, Hoctin A, Hoffmann I, Houas I, Hulot J, Jaafoura S, Kafif O, Kaguelidou F, Kali S, Kerroumi Y, Khalil A, Khan C, Kimmoun A, Laine F, Laouénan C, Laribi S, Le M, Le Bris C, Le Gac S, Le Hingrat Q, Le Mestre S, Le Nagard H, Lemaignen A, Lemee V, Lescure F, Letrou S, Levy Y, Lina B, Lingas G, Lucet J, Machado M, Malvy D, Mambert M, Manuel A, Mentré F, Meziane A, Mouquet H, Mullaert J, Neant N, Nguyen D, Noret M, Papadopoulos A, Paul C, Peiffer-Smadja N, Peigne V, Petrov-Sanchez V, Peytavin G, Pham H, Picone O, Piquard V, Poissy J, Puéchal O, Rosa-Calatrava M, Rossignol B, Rossignol P, Roy C, Schneider M, Su R, Tardivon C, Tellier M, Téoulé F, Terrier O, Timsit J, Tual C, Tubiana S, Van Der Werf S, Vanel N, Veislinger A, Visseaux B, Wiedemann A, Yazdanpanah Y, Annereau J, Briseño-Roa L, Gribouval O, Jaïs J, Pelet A, Abel L, Alcover A, Aschard H, Bousso P, Bourke N, Brodin P, Bruhns P, Cerf-Bensussan N, Cumano A, D’Enfert C, Deriano L, Dillies M, Di Santo J, Dromer F, Eberl G, Enninga J, Fellay J, Gomperts-Boneca I, Hasan M, Hedestam G, Hercberg S, Ingersoll M, Lantz O, Kenny R, Ménager M, Michel F, Mouquet H, O’Farrelly C, Patin E, Pellegrini S, Rausell A, Rieux-Laucat F, Rogge L, Fontes M, Sakuntabhai A, Schwartz O, Schwikowski B, Shorte S, Tangy F, Toubert A, Touvier M, Ungeheuer M, Zimmer C, Albert M, Duffy D, Quintana-Murci L, Alavoine L, Behillil S, Burdet C, Charpentier C, Dechanet A, Descamps D, Duval X, Ecobichon J, Enouf V, Frezouls W, Houhou N, Kafif O, Lehacaut J, Letrou S, Lina B, Lucet J, Manchon P, Nouroudine M, Piquard V, Quintin C, Thy M, Tubiana S, van der Werf S, Vignali V, Visseaux B, Yazdanpanah Y, Chahine A, Waucquier N, Migaud M, Deplanque D, Djossou F, Mergeay-Fabre M, Lucarelli A, Demar M, Bruneau L, Gérardin P, Maillot A, Payet C, Laviolle B, Laine F, Paris C, Desille-Dugast M, Fouchard J, Malvy D, Nguyen D, Pistone T, Perreau P, Gissot V, Le Goas C, Montagne S, Richard L, Chirouze C, Bouiller K, Desmarets M, Meunier A, Bourgeon M, Lefèvre B, Jeulin H, Legrand K, Lomazzi S, Tardy B, Gagneux-Brunon A, Bertholon F, Botelho-Nevers E, Kouakam C, Leturque N, Roufai L, Amat K, Couffin-Cadiergues S, Espérou H, Hendou S, van Agtmael M, Algera A, Appelman B, van Baarle F, Bax D, Beudel M, Bogaard H, Bomers M, Bonta P, Bos L, Botta M, de Brabander J, de Bree G, de Bruin S, Buis D, Bugiani M, Bulle E, Chouchane O, Cloherty A, Dijkstra M, Dongelmans D, Dujardin R, Elbers P, Fleuren L, Geerlings S, Geijtenbeek T, Girbes A, Goorhuis B, Grobusch M, Hafkamp F, Hagens L, Hamann J, Harris V, Hemke R, Hermans S, Heunks L, Hollmann M, Horn J, Hovius J, de Jong M, Koning R, Lim E, van Mourik N, Nellen J, Nossent E, Paulus F, Peters E, Pina-Fuentes D, van der Poll T, Preckel B, Prins J, Raasveld J, Reijnders T, de Rotte M, Schinkel M, Schultz M, Schrauwen F, Schuurman A, Schuurmans J, Sigaloff K, Slim M, Smeele P, Smit M, Stijnis C, Stilma W, Teunissen C, Thoral P, Tsonas A, Tuinman P, van der Valk M, Veelo D, Volleman C, de Vries H, Vught L, van Vugt M, Wouters D, Zwinderman A, Brouwer M, Wiersinga W, Vlaar A, van de Beek D, Abel L, Aiuti A, Al-Muhsen S, Al-Mulla F, Anderson M, Andreakos E, Arias A, Feldman H, Belot A, Biggs C, Bogunovic D, Bolze A, Bondarenko A, Bousfiha A, Brodin P, Bryceson Y, Bustamante C, Butte M, Casari G, Chakravorty S, Christodoulou J, Condino-Neto A, Constantinescu S, Cooper M, Dalgard C, Desai M, Drolet B, Baghdadi J, Espinosa-Padilla S, Fellay J, Flores C, Franco J, Froidure A, Gregersen P, Haerynck F, Hagin D, Halwani R, Hammarström L, Heath J, Henrickson S, Hsieh E, Husebye E, Imai K, Itan Y, Jarvis E, Karamitros T, Kisand K, Ku C, Lau Y, Ling Y, Lucas C, Maniatis T, Mansouri D, Maródi L, Meyts I, Milner J, Mironska K, Mogensen T, Morio T, Ng L, Notarangelo L, Novelli A, Novelli G, O’Farrelly C, Okada S, Ozcelik T, Pan-Hammarström Q, de Diego R, Planas A, Perez-Tur J, Arkin L, Asano T, Oriol R, Prando C, Pujol A, Quintana-Murci L, Renia L, Resnick I, Rodríguez-Gallego C, Sancho-Shimizu V, Sediva A, Seppänen M, Shahrooei M, Shcherbina A, Slaby O, Snow A, Soler-Palacín P, Spaan A, Tancevski I, Tangye S, Tayoun A, Ramaswamy S, Turvey S, Uddin K, Uddin M, van de Beek D, Vinh D, von Bernuth H, Zatz M, Zawadzki P, Grimbacher B, Okamoto K, Pape J, Perlin D, Pesole G, Wauters J, Su H, Casanova J, García P, López G, Rojas-Villaraga A, Vélez V, Landinez L, Correales L, Gómez O, Guaqueta J, Pérez C, Carrillo J, Vergara J, Landinez S, Mantilla R, Yepes J, Ricaurte O, Pérez-Díaz C, Mateus Y, Navarro L, Rodríguez Y, Acosta-Ampudia Y, Monsalve D, Rojas M, Nadif R, Goldberg M, Ozguler A, Henny J, Lemonnier S, Coeuret-Pellicer M, Le Got S, Zins M, Tzourio C, Debette S, Dufouil C, Soumaré A, Lachaize M, Fievet N, Flaig A, Martin F, Bonneaudeau B, Cognasse F, Cannet D, Gallian P, Jeanne M, Morel P, Perroquin M, Richard P, Tiberghien P, Hamzeh-Cognasse H. The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies. Proceedings Of The National Academy Of Sciences Of The United States Of America 2022, 119: e2200413119. PMID: 35576468, PMCID: PMC9173764, DOI: 10.1073/pnas.2200413119.Peer-Reviewed Original ResearchThe experience of anaesthesiology care providers in temporary intensive care units during the COVID-19 pandemic in France: a qualitative study
Guessoum S, Marvaldi M, Thomas I, Lachal J, Carretier E, Moro M, Benoit L. The experience of anaesthesiology care providers in temporary intensive care units during the COVID-19 pandemic in France: a qualitative study. Anaesthesia Critical Care & Pain Medicine 2022, 41: 101061. PMID: 35472584, PMCID: PMC9035661, DOI: 10.1016/j.accpm.2022.101061.Peer-Reviewed Original ResearchConceptsIntensive care unitCare providersCare unitCOVID-19 pandemicInfection control protocolsHigh fatality ratePublic health policyCOVID-19 pandemic's first waveIll patientsFirst waveUniversity HospitalCare settingsLife careFatality rateQualitative studyDisruption of relationshipsHealth policyPandemic's first wavePatientsPsychological impactCareLack of recognitionLack of knowledgeNew diseaseInterpretative phenomenological analysisSARS CoV-2 seroprevalence and diagnostic accuracy during a COVID-19 outbreak in a major penitentiary complex in Brazil, June to July 2020
Gouvea-Reis F, da Silva D, Borja L, de Oliveira Dias P, Percio J, Peterka C, de Oliveira J, Sodré G, Feres C, Dos Santos W, Souza F, Teixeira A, Cilião-Alves D, Romero G, Noronha E, Croda J, Haddad R, Ramalho W, de Moraes C, de Araújo W. SARS CoV-2 seroprevalence and diagnostic accuracy during a COVID-19 outbreak in a major penitentiary complex in Brazil, June to July 2020. International Journal Of Prison Health 2022, 19: 143-156. PMID: 38899623, DOI: 10.1108/ijph-08-2021-0083.Peer-Reviewed Original ResearchSARS-CoV-2 seroprevalenceOverall infection fatality rateInfection fatality rateChemiluminescence enzyme immunoassaySymptomatic individualsOverall SARS-CoV-2 seroprevalenceSARS-CoV-2 antibodiesDiagnostic accuracyAntibody rapid testLateral flow immunochromatographic assayCOVID-19 outbreakAsymptomatic infectionVaccination strategiesEligible individualsHigh seroprevalenceFatality ratePositive casesSeroprevalenceSerological assaysEnzyme immunoassayRapid testPriority groupsMass testingLFIA testRepresentative sample
2021
SARS-CoV-2 Infection Fatality Rates in India: Systematic Review, Meta-analysis and Model-based Estimation
Zimmermann L, Bhattacharya S, Purkayastha S, Kundu R, Bhaduri R, Ghosh P, Mukherjee B. SARS-CoV-2 Infection Fatality Rates in India: Systematic Review, Meta-analysis and Model-based Estimation. Studies In Microeconomics 2021, 9: 137-179. DOI: 10.1177/23210222211054324.Peer-Reviewed Original ResearchStudy end dateExcess deathsMeta-analysisCase fatality rateState-specific estimatesGlobal Index MedicusEnd dateFatality rateSARS-CoV-2-related deathInfection fatality rateSARS-CoV-2 infection fatality rateRandom-effects modelDeath dataDeath reportingExcess death estimatesImprove death reportingNationwide estimatesSystematic reviewDatabases PubMedPRISMA guidelinesWave 2DerSimonian-Laird estimatorSystematic searchWave 1Model-based estimatesNo Effects of Meteorological Factors on the SARS-CoV-2 Infection Fatality Rate
Solanes A, Laredo C, Guasp M, Fullana M, Fortea L, Garcia-Olivé I, Solmi M, Shin J, Urra X, Radua J. No Effects of Meteorological Factors on the SARS-CoV-2 Infection Fatality Rate. Biomedical And Environmental Sciences 2021, 34: 871-880. PMID: 34955147, PMCID: PMC8690129, DOI: 10.3967/bes2021.120.Peer-Reviewed Original ResearchEstimating the wave 1 and wave 2 infection fatality rates from SARS-CoV-2 in India
Purkayastha S, Kundu R, Bhaduri R, Barker D, Kleinsasser M, Ray D, Mukherjee B. Estimating the wave 1 and wave 2 infection fatality rates from SARS-CoV-2 in India. BMC Research Notes 2021, 14: 262. PMID: 34238344, PMCID: PMC8264482, DOI: 10.1186/s13104-021-05652-2.Peer-Reviewed Original ResearchConceptsFatality rateRelative risks of COVID-19 fatality between the first and second waves of the pandemic in Ontario, Canada
Hsu SH, Chang SH, Gross C, Wang SY. Relative risks of COVID-19 fatality between the first and second waves of the pandemic in Ontario, Canada. International Journal Of Infectious Diseases 2021, 109: 189-191. PMID: 34216734, PMCID: PMC8245301, DOI: 10.1016/j.ijid.2021.06.059.Peer-Reviewed Original ResearchConceptsCase fatality rateRelative riskTesting ratesPooled RR estimateCOVID-19 case fatality ratePublic health unitsCOVID-19 case fatalityCOVID-19 testingCOVID-19 testing ratesHigher testing ratesCase fatalityCOVID-19 casesCOVID-19 fatalitiesHealth unitsFatality rateSecond waveRR estimatesFirst waveCOVID-19RiskFatalitiesOntarioSARS-CoV-2 Infection Hospitalization Rate and Infection Fatality Rate Among the Non-Congregate Population in Connecticut
Mahajan S, Caraballo C, Li SX, Dong Y, Chen L, Huston SK, Srinivasan R, Redlich CA, Ko AI, Faust JS, Forman HP, Krumholz HM. SARS-CoV-2 Infection Hospitalization Rate and Infection Fatality Rate Among the Non-Congregate Population in Connecticut. The American Journal Of Medicine 2021, 134: 812-816.e2. PMID: 33617808, PMCID: PMC7895685, DOI: 10.1016/j.amjmed.2021.01.020.Peer-Reviewed Original ResearchConceptsInfection hospitalization rateInfection fatality rateHospitalization ratesFatality rateSeroprevalence estimatesSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodiesSARS-CoV-2 antibodiesConnecticut Hospital AssociationNon-Hispanic black peopleProportion of deathsCoronavirus disease 2019Total infected individualsTotal hospitalizationsAdverse outcomesNon-congregate settingsHigh burdenDisease 2019Prevalence studyMost subgroupsInfected individualsHospitalizationOlder peopleHospital AssociationConnecticut DepartmentDeath
2020
Comprehensive public health evaluation of lockdown as a non-pharmaceutical intervention on COVID-19 spread in India: national trends masking state-level variations
Salvatore M, Basu D, Ray D, Kleinsasser M, Purkayastha S, Bhattacharyya R, Mukherjee B. Comprehensive public health evaluation of lockdown as a non-pharmaceutical intervention on COVID-19 spread in India: national trends masking state-level variations. BMJ Open 2020, 10: e041778. PMID: 33303462, PMCID: PMC7733201, DOI: 10.1136/bmjopen-2020-041778.Peer-Reviewed Original ResearchConceptsEffective public health interventionsPublic health interventionsPublic health evaluationPublic health metricsAverage daily numberHealth interventionsState-level trendsHealth metricsTest positivity rateCohort studyCase fatality rateHealth evaluationNational trendsCOVID-19Holistic assessmentDaily numberConfirmed COVID-19 CasesCOVID-19 pandemicNational patternsNational lockdownInterventionCOVID-19 outbreakFatality rateCase countsState-wise variationsPresentation, Treatment, and Outcomes of the Oldest-Old Patients with Acute Myocardial Infarction: The SILVER-AMI Study
Gupta A, Tsang S, Hajduk A, Krumholz HM, Nanna MG, Green P, Dodson JA, Chaudhry SI. Presentation, Treatment, and Outcomes of the Oldest-Old Patients with Acute Myocardial Infarction: The SILVER-AMI Study. The American Journal Of Medicine 2020, 134: 95-103. PMID: 32805225, PMCID: PMC7752813, DOI: 10.1016/j.amjmed.2020.07.020.Peer-Reviewed Original ResearchConceptsOldest-old patientsMyocardial infarctionFunctional impairmentOlder patientsMobility impairmentsCox proportional hazards regressionMiddle-old patientsProportional hazards regressionAcute myocardial infarctionCase fatality rateAcute myocardial infarction hospitalizationsSILVER-AMI StudyYears of ageMyocardial infarction hospitalizationsChest painCoronary revascularizationAtypical presentationHazards regressionClinical variablesRisk factorsAdvanced agePrimary symptomsPatientsFatality rateHealth statusMouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling
Israelow B, Song E, Mao T, Lu P, Meir A, Liu F, Alfajaro MM, Wei J, Dong H, Homer RJ, Ring A, Wilen CB, Iwasaki A. Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling. Journal Of Experimental Medicine 2020, 217: e20201241. PMID: 32750141, PMCID: PMC7401025, DOI: 10.1084/jem.20201241.Peer-Reviewed Original ResearchMeSH KeywordsAngiotensin-Converting Enzyme 2AnimalsBetacoronavirusCell Line, TumorCoronavirus InfectionsCOVID-19DependovirusDisease Models, AnimalFemaleHumansInflammationInterferon Type ILungMaleMiceMice, Inbred C57BLMice, TransgenicPandemicsParvoviridae InfectionsPeptidyl-Dipeptidase APneumonia, ViralSARS-CoV-2Signal TransductionVirus ReplicationConceptsSARS-CoV-2Type I interferonMouse modelI interferonRobust SARS-CoV-2 infectionSevere acute respiratory syndrome coronavirus 2Acute respiratory syndrome coronavirus 2SARS-CoV-2 infectionRespiratory syndrome coronavirus 2SARS-CoV-2 replicationCOVID-19 patientsSyndrome coronavirus 2Patient-derived virusesSignificant fatality ratePathological findingsInflammatory rolePathological responseEnzyme 2Receptor angiotensinFatality rateVaccine developmentGenetic backgroundViral replicationCoronavirus diseaseMiceCOVID-19 in South Korea: epidemiological and spatiotemporal patterns of the spread and the role of aggressive diagnostic tests in the early phase
Lee W, Hwang SS, Song I, Park C, Kim H, Song IK, Choi HM, Prifti K, Kwon Y, Kim J, Oh S, Yang J, Cha M, Kim Y, Bell ML, Kim H. COVID-19 in South Korea: epidemiological and spatiotemporal patterns of the spread and the role of aggressive diagnostic tests in the early phase. International Journal Of Epidemiology 2020, 49: 1106-1116. PMID: 32754756, PMCID: PMC7454567, DOI: 10.1093/ije/dyaa119.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAged, 80 and overBetacoronavirusChildChild, PreschoolClinical Laboratory TechniquesCoronavirusCoronavirus InfectionsCOVID-19COVID-19 TestingDiagnostic Tests, RoutineDisease OutbreaksHumansInfantInfant, NewbornMiddle AgedMortalityPandemicsPneumonia, ViralRepublic of KoreaSARS-CoV-2Spatio-Temporal AnalysisConceptsCOVID-19Aggressive diagnostic testsCase fatality rateNovel coronavirus disease (COVID-19) outbreakWidespread diagnostic testingEpidemic doubling timeSevere patientsCoronavirus disease (COVID-19) outbreakPatient care systemsInitial RTFatality rateTreatment policyDiagnostic testingFatality patternsDiagnostic testsDaily reproduction numberCare systemUnprecedented pandemicAggressive testingEarly epidemic phaseMedical resourcesEpidemic phaseEarly phaseDaysDisease outbreaksGestational outcomes in women infected by Zika virus during pregnancy in Mato Grosso do Sul, Brazil: A cross-sectional study
Sousa I, Souza C, Barbosa M, Croda J, Gonçalves C, Bernardes S, Marchioro S. Gestational outcomes in women infected by Zika virus during pregnancy in Mato Grosso do Sul, Brazil: A cross-sectional study. International Journal Of Infectious Diseases 2020, 98: 359-365. PMID: 32619757, DOI: 10.1016/j.ijid.2020.06.084.Peer-Reviewed Original ResearchConceptsCongenital Zika syndromeZIKV infectionCross-sectional studyGestational outcomesZika virusNormal-appearing infantMain clinical findingsCase fatality rateMother-infant pairsMothers of infantsQRT-PCRZika syndromeClinical caveatsClinical findingsClinical parametersFirst trimesterCongenital alterationsLive birthsLaboratory confirmationCongenital abnormalitiesFatality rateEpidemic burstsInfectionPregnancyInfants
2019
Trends of admissions and case fatality rates among medical in-patients at a tertiary hospital in Uganda; A four-year retrospective study
Kalyesubula R, Mutyaba I, Rabin T, Andia-Biraro I, Alupo P, Kimuli I, Nabirye S, Kagimu M, Mayanja-Kizza H, Rastegar A, Kamya MR. Trends of admissions and case fatality rates among medical in-patients at a tertiary hospital in Uganda; A four-year retrospective study. PLOS ONE 2019, 14: e0216060. PMID: 31086371, PMCID: PMC6516645, DOI: 10.1371/journal.pone.0216060.Peer-Reviewed Original ResearchConceptsTrend of admissionsCase fatality rateAnnual percentage changeHIV/AIDSFatality rateMedical wardsDual burdenFour-year retrospective studyHigh case fatality ratePercentage changeNon-TB pneumoniaChronic kidney diseaseDate of dischargeCause of hospitalizationMajority of patientsProportion of hospitalizationsDate of admissionProportion of admissionsRisk of deathCause of morbidityAdult medical wardsDate of deathNon-communicable diseasesNon-infectious diseasesHealth system improvement
2017
Incidence of myocardial infarction in pregnancy: a systematic review and meta-analysis of population-based studies
Gibson P, Narous M, Firoz T, Chou D, Barreix M, Say L, James M, Group O. Incidence of myocardial infarction in pregnancy: a systematic review and meta-analysis of population-based studies. European Heart Journal - Quality Of Care And Clinical Outcomes 2017, 3: 198-207. PMID: 28838086, PMCID: PMC5862024, DOI: 10.1093/ehjqcco/qcw060.Peer-Reviewed Original ResearchConceptsPregnancy-associated myocardial infarctionCase fatality rateMyocardial infarctionMaternal mortalitySystematic reviewIndirect maternal deathsMaternal myocardial infarctionPooled incidence estimatesCardiovascular risk factorsPopulation-based cohortPopulation-based studyCase-control studyHigh rateMaternal incidencePooled incidenceMaternal deathsCommon etiologyMaternal ageRisk factorsIncidence estimatesCardiac diseaseDate restrictionsMortality rateFatality rateElectronic databases
2016
Situation of Sri Lanka, where autochthonous malaria is no longer a problem, and other infections dominate, such as dengue, leptospirosis and rickettsioses
Agampodi S, Wijerathne B, Weerakoon K. Situation of Sri Lanka, where autochthonous malaria is no longer a problem, and other infections dominate, such as dengue, leptospirosis and rickettsioses. Current Opinion In Infectious Diseases 2016, 29: 446-452. PMID: 27479026, DOI: 10.1097/qco.0000000000000303.Peer-Reviewed Original ResearchConceptsAutochthonous malariaCase fatality rateCommunicable disease controlReduction of malariaCommunicable disease control programmesControl programsClinical managementMalaria casesDisease control programsFatality rateCommunicable diseasesSuccessful control programsMalaria controlDisease controlInfectious diseasesMalariaDiseaseTropical diseasesDiagnostic facilitiesVector control activitiesLeptospirosisDengueTime trendsVector-borne diseasesRickettsiosesMacrovascular Lesions Underlying Spontaneous Intracerebral Hemorrhage
Yeung J, Cord BJ, O'Rourke TK, Maina RM, Sommaruga S, Matouk CC. Macrovascular Lesions Underlying Spontaneous Intracerebral Hemorrhage. Seminars In Neurology 2016, 36: 244-253. PMID: 27214699, DOI: 10.1055/s-0036-1581994.Peer-Reviewed Original ResearchConceptsSpontaneous intracerebral hemorrhageIntracerebral hemorrhageMacrovascular lesionsHigh case fatality rateCranial dural arteriovenous fistulasBrain arteriovenous malformationsCase fatality rateDural arteriovenous fistulaEtiology of hemorrhageCerebral cavernous malformationsRehemorrhage rateArteriovenous fistulaMorbid diseaseArteriovenous malformationsCavernous malformationsFatality rateClinical decisionHemorrhageLesionsMalformationsFistulaPrognosisAneurysmsEtiologyDisease
2015
Pneumococcal Disease in the Era of Pneumococcal Conjugate Vaccine
Yildirim I, Shea KM, Pelton SI. Pneumococcal Disease in the Era of Pneumococcal Conjugate Vaccine. Infectious Disease Clinics Of North America 2015, 29: 679-697. PMID: 26610421, PMCID: PMC4662776, DOI: 10.1016/j.idc.2015.07.009.Peer-Reviewed Original ResearchConceptsPneumococcal conjugate vaccinePneumococcal diseaseConjugate vaccineOtitis mediaUniversal immunizationAcute otitis mediaInvasive pneumococcal diseaseCase fatality rateVulnerable pediatric patientsSpectrum of serotypesCause pneumoniaPediatric patientsComorbid conditionsHealthy childrenFatality rateDiseaseHost susceptibilityImmunizationVaccineHigh rateChildrenEmpyemaMastoiditisPneumoniaPatients
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply